Koizumi H, Onozuka Y, Shibata M, Sano K, Ooshima Y, Morizane T, Ueno Y
Kawasaki Social Insurance Hospital, Kawasaki 210-0822.
Rinsho Byori. 2000 Oct;48(10):966-70.
Anti-mitochondrial antibody(AMA) has been reported to be detectable in approximately 85% of patients with primary biliary cirrhosis(PBC). Therefore, a test for AMA is acceptable to be essential for diagnosing PBC. However, the positive rate in Japanese general population has not yet been determined. We tested sera from 1,145 corporate workers who took an annual health check and evaluated the liver of AMA-positive subjects. An indirect immunofluorescence method was used for screening AMA. ELISA and immunoblotting method were used for detecting anti-M2 in AMA-positive cases. AMA was detected in 5 of 1,145(0.44%) corporate workers. AMA positive rate was higher in females than in males(0.91% and 0%, respectively) and the AMA-positive people are all females over age 40. All of the AMA-positive sera are also positive for Anti-M2. Liver biopsy was performed in two AMA-positive cases and the histology was compatible with PBC in both cases.
据报道,约85%的原发性胆汁性肝硬化(PBC)患者可检测到抗线粒体抗体(AMA)。因此,AMA检测对于诊断PBC至关重要。然而,日本普通人群中的阳性率尚未确定。我们检测了1145名接受年度健康检查的公司员工的血清,并对AMA阳性受试者的肝脏进行了评估。采用间接免疫荧光法筛查AMA。采用酶联免疫吸附测定(ELISA)和免疫印迹法检测AMA阳性病例中的抗M2抗体。在1145名公司员工中,有5人(0.44%)检测到AMA。女性的AMA阳性率高于男性(分别为0.91%和0%),且AMA阳性者均为40岁以上的女性。所有AMA阳性血清的抗M2抗体也呈阳性。对2例AMA阳性病例进行了肝活检,两例组织学结果均符合PBC。